Publicacións en colaboración con investigadores/as de Azienda Ospedaliero-Universitaria Careggi (28)

2023

  1. Phase 2 Study of Aficamten in Patients With Obstructive Hypertrophic Cardiomyopathy

    Journal of the American College of Cardiology, Vol. 81, Núm. 1, pp. 34-45

  2. Rest and Stress Left Atrial Dysfunction in Patients with Atrial Fibrillation

    Journal of Clinical Medicine, Vol. 12, Núm. 18

2022

  1. Characteristics, management, and outcomes of patients with left-sided infective endocarditis complicated by heart failure: a substudy of the ESC-EORP EURO-ENDO (European infective endocarditis) registry

    European Journal of Heart Failure, Vol. 24, Núm. 7, pp. 1253-1265

  2. Clinical Features and Natural History of Preadolescent Nonsyndromic Hypertrophic Cardiomyopathy

    Journal of the American College of Cardiology, Vol. 79, Núm. 20, pp. 1986-1997

  3. Impact of SARS-Cov-2 infection in patients with hypertrophic cardiomyopathy: results of an international multicentre registry

    ESC Heart Failure, Vol. 9, Núm. 4, pp. 2189-2198

  4. Left atrial volume changes during exercise stress echocardiography in heart failure and hypertrophic cardiomyopathy

    Hellenic Journal of Cardiology, Vol. 67, pp. 9-18

  5. Pulmonary congestion during Exercise stress Echocardiography in Hypertrophic Cardiomyopathy

    International Journal of Cardiovascular Imaging

  6. The role of the electrocardiographic phenotype in risk stratification for sudden cardiac death in childhood hypertrophic cardiomyopathy

    European Journal of Preventive Cardiology, Vol. 29, Núm. 4, pp. 645-653

2021

  1. Aortic valve replacement: validation of the Toronto Aortic Stenosis Quality of Life Questionnaire

    ESC Heart Failure, Vol. 8, Núm. 1, pp. 270-279

  2. Cardiac Involvement in Fabry Disease: JACC Review Topic of the Week

    Journal of the American College of Cardiology, Vol. 77, Núm. 7, pp. 922-936

  3. Differences between familial and sporadic dilated cardiomyopathy: ESC EORP Cardiomyopathy & Myocarditis registry

    ESC Heart Failure, Vol. 8, Núm. 1, pp. 95-105

  4. Feasibility and functional correlates of left atrial volume changes during stress echocardiography in chronic coronary syndromes

    International Journal of Cardiovascular Imaging, Vol. 37, Núm. 3, pp. 953-964

  5. Prognostic value of reduced heart rate reserve during exercise in hypertrophic cardiomyopathy

    Journal of Clinical Medicine, Vol. 10, Núm. 7

  6. Quality of life after transcatheter or surgical aortic valve replacement using the Toronto Aortic Stenosis Quality of Life Questionnaire

    Open Heart, Vol. 8, Núm. 2

  7. Severe Valvular Heart Disease and COVID-19: Results from the Multicenter International Valve Disease Registry

    Structural Heart, Vol. 5, Núm. 4, pp. 424-426

  8. Stress echo 2030: The novel ABCDE-(FGLPR) protocol to define the future of imaging

    Journal of Clinical Medicine, Vol. 10, Núm. 16

2020

  1. Clinical Features and Natural History of PRKAG2 Variant Cardiac Glycogenosis

    Journal of the American College of Cardiology, Vol. 76, Núm. 2, pp. 186-197

  2. Correction to: Two-year follow-up of one-stage left unilateral thoracoscopic epicardial and transcatheter endocardial ablation for persistent and long-standing persistent atrial fibrillation (Journal of Interventional Cardiac Electrophysiology, (2020), 58, 3, (333-343), 10.1007/s10840-019-00616-w)

    Journal of Interventional Cardiac Electrophysiology

  3. Left atrial appendage occlusion for stroke despite oral anticoagulation (resistant stroke). Results from the Amplatzer Cardiac Plug registry

    Revista Espanola de Cardiologia, Vol. 73, Núm. 1, pp. 28-34

  4. Mavacamten for treatment of symptomatic obstructive hypertrophic cardiomyopathy (EXPLORER-HCM): a randomised, double-blind, placebo-controlled, phase 3 trial

    The Lancet, Vol. 396, Núm. 10253, pp. 759-769